LeBlanc, R., S. Hollmann, and J. Tay. “CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 23, no. 1, Nov. 2018, https://jptcp.com/index.php/jptcp/article/view/237.